Download Free Neuropsychology Of Cognitive Decline Book in PDF and EPUB Free Download. You can read online Neuropsychology Of Cognitive Decline and write the review.

Presenting best practices for assessment and intervention with older adults experiencing cognitive decline, this book draws on cutting-edge research and extensive clinical experience. The authors' integrative approach skillfully interweaves neuropsychological and developmental knowledge. The volume provides guidelines for evaluating and differentiating among normal aging, subjective cognitive decline, mild cognitive impairment, and different types of dementia. It identifies risk and protective factors that may influence an individual's trajectory and describes how to create a sound case conceptualization. Evidence-based strategies for pharmacological, cognitive, behavioral, and psychological intervention with patients and their caregivers are illustrated with vivid case examples.ÿ ÿ
Presenting best practices for assessment and intervention with older adults experiencing cognitive decline, this book draws on cutting-edge research and extensive clinical experience. The authors' integrative approach skillfully interweaves neuropsychological and developmental knowledge. The volume provides guidelines for evaluating and differentiating among normal aging, subjective cognitive decline, mild cognitive impairment, and different types of dementia. It identifies risk and protective factors that may influence an individual's trajectory and describes how to create a sound case conceptualization. Evidence-based strategies for pharmacological, cognitive, behavioral, and psychological intervention with patients and their caregivers are illustrated with vivid case examples.
With the aging of the baby boomers and medical advances that promote longevity, older adults are rapidly becoming the fastest growing segment of the population. As the population ages, so does the incidence of age related disorders. Many predict that 15% - 20% of the baby-boomer generation will develop some form of cognitive decline over the course of their lifetime, with estimates escalating to up to 50% in those achieving advanced age. Although much attention has been directed at Alzheimer’s disease, the most common form of dementia, it is estimated that nearly one third of those cases of cognitive decline result from other neuropathological mechanisms. In fact, many patients diagnosed with Alzheimer’s disease likely have co-morbid disorders that can also influence cognition (i.e., vascular cognitive impairment), suggesting mixed dementias are grossly under diagnosed. The Clinical Handbook on the Neuropsychology of Aging and Dementia is a unique work that provides clinicians with expert guidance and a hands-on approach to neuropsychological practice with older adults. The book will be divided into two sections, the first addressing special considerations for the evaluation of older adults, and the second half focusing on common referral questions likely to be encountered when working with this age group. The authors of the chapters are experts and are recognized by their peers as opinion leaders in their chosen chapter topics. The field of neuropsychology has played a critical role in developing methods for early identification of late life cognitive disorders as well as the differential diagnosis of dementia. Neuropsychological assessment provides valuable clinical information regarding the nature and severity of cognitive symptoms associated with dementia. Each chapter will reinforce the notion that neuropsychological measures provide the clinician with sensitive tools to differentiate normal age-related cognitive decline from disease-associated impairment, aid in differential diagnosis of cognitive dysfunction in older adults, as well as identify cognitive deficits most likely to translate into functional impairments in everyday life.
This book describes the latest advances in our psychological understanding of Alzheimer's disease, bringing together the main experts in this field to describe recent developments. It will be valuable for people working in related disciplines, such as neurology, psychiatry and neuroscience researchers, as well as providing an introduction to the field for psychologists.
The Classic Edition of this foundational text includes a new preface from Holly A. Tuokko, examining how the field of Mild Cognitive Impairment (MCI) has developed since first publication. Bringing together research from multiple studies and perspectives from various countries, the volume identifies MCI as an important clinical transition between normal aging and the early stages of Alzheimer's disease (AD). The up-to-date preface highlights the expansion in research, examining the benefits of various pharmacological, cognitive and behavioral approaches to intervention. Influenced by recent findings in neuroplasticity across the lifespan, the book recognizes the importance of intervention at the earliest stages of the decline trajectory. It revisits the contested diagnostic approaches for MCI as well as the varying prevalence of MCI internationally, yet points to the need for further longitudinal studies to fully understand the condition. Mild Cognitive Impairment continues to provide a comprehensive resource for clinicians, researchers and students involved in the study, diagnosis, treatment and rehabilitation of people with MCI.
Alzheimer disease (AD) has become the most common form of dementia in industrialized countries and represents an increasing burden at the economic, social and medical level. In discussing both the biological aspects of AD as well as the cognitive functions involved, Alzheimer Disease - Neuropsychology and Pharmacology presents a comprehensive picture of the pathology and approaches to diagnosis and treatment. Basic research including animal models, molecular and genetic aspects is also taken into consideration. In part I, the biological correlates of AD are discussed. In part II the neuropsychological aspects such as cognitive impairment, loss of functional autonomy and emergence of neuropsychiatric disturbances of AD are outlined. In part III, strategies for effective treatment and prevention of AD are discussed. This book will be a useful source of information for clinicians as well as researchers in the area of neuropharmacology.
The go-to resource for assessing and predicting functional abilities in persons with brain injury or cognitive decline has now been revised and expanded to reflect significant advances in the field. With a focus on key real-world capacities--independent living, vocational functioning, medication management, and driving--leading experts explore how individuals go about their daily lives, where and why disruptions occur, and potential opportunities for improving function. Strategies for direct assessment are reviewed, from standard neuropsychological tests to multimodal approaches and technology-based tools. Chapters also provide functional assessment guidance for specific neurological and psychiatric conditions: dementia, traumatic brain injury, depression, schizophrenia, and others. New to This Edition *Incorporates over a decade of technological and methodological innovations. *Chapter on theories and models of everyday functioning. *Chapters on naturalistic assessment, wearable sensors, ambulatory assessment, and virtual-reality-based tools. *Practical clinical implications are highlighted throughout.
What are the boundary zones between normal aging and Alzheimer's disease (AD)? Are many elderly people whom we regard as normal actually in the early stages of AD? Alzheimer's disease does not develop overnight; the early phases may last for years or even decades. Recently, clinical investigators have identified a transitional condition between normal aging and and very early Alzheimer's disease that they have called mild cognitive impairment, or MCI. This term typically refers to memory impairment beyond what one would expect in individuals of a given age whose other abilities to function in daily life are well preserved. Persons who meet the criteria for mild cognitive impairment have an increased risk of progressing to Alzheimer's disease in the near future. Though many questions about this condition and its underlying neuropathology remain open, full clinical trials are currently underway worldwide aimed at preventing the progression from MCI to Alzheimer's disease. This book addresses the spectrum of issues involved in mild cognitive impairment, and includes chapters on clinical studies, neuropsychology, neuroimaging, neuropathology, biological markers, diagnostic approaches, and treatment. It is intended for clinicians, researchers, and students interested in aging and cognition, among them neurologists, psychiatrists, geriatricians, clinical psychologists, and neuropsychologists.
Compiled reviews of the recent literature are a long established tradition in the laboratory and clinical sciences, and bring to their professions a useful and timely summary of the advances that have been made in the field. Neuropsychology has matured as a science and profession to support a like effort to summarize, across domains, the direction and momentum in the field. The authors are authorities in the subjects they review and provide for the investigator, practitioner and student an overview of the important developments in neuropsychology that cannot be realized from perusal of the journals alone. Interest in the reviews are likely to go beyond the discipline of neuropsychology, and will extend to all with an interest in science of brain-behavior relationships, in the study of disease and injury as they affect brain function, and in the rehabilitation of the individual who has suffered insult to brain. Chapters cover the pragmatic application of tests and test findings to improve our understanding of the behavior of individuals who present with neurocognitive disorders. Where there is interest in efficiently acquiring a sound perspective of the important advances and the future direction of neuropsychology, Neuropsychology: A Review of Science and Practice will provide the means for so doing as no other publication can offer.
This handbook celebrates the abundantly productive interaction of neuropsychology and medicine. This interaction can be found in both clinical settings and research l- oratories, often between research teams and clinical practitioners. It accounts for the rapidity with which awareness and understanding of the neuropsychological com- nents of many common medical disorders have recently advanced. The introduction of neuropsychology into practice and research involving conditions without obvious neurological components follows older and eminently successful models of integrated care and treatment of the classical brain disorders. In the last 50 years, with the growing understanding of neurological disorders, neuropsychologists and medical specialists in clinics, at bedside, and in laboratories together have contributed to important clinical and scienti c advances in the und- standing of the common pathological conditions of the brain: stroke, trauma, epilepsy, certain movement disorders, tumor, toxic conditions (mostly alcohol-related), and degenerative brain diseases. It is not surprising that these seven pathological con- tions were the rst to receive attention from neuropsychologists as their behavioral symptoms can be both prominent and debilitating, often with serious social and economic consequences.